Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet
The Benzinga Stock Whisper looks at five stocks seeing a surge in interest from readers during the week and the potential reasons why. read more
Read More
Terra Luna Co-Founder Do Kwon To Be Extradited To The US: Report
Montenegro’s Minister of Justice, Bojan Božović on Friday authorized the extradition of Terraform Labs co-founder Do Kwon to the United States, concluding months of legal wrangling over competing extradition requests from the read more
Sam Altman’s OpenAI Plans Major Restructuring to Non-Profit Structure Amid Rising Costs
OpenAI plans to restructure into a for-profit company in 2025, highlighting the need for significant capital. This move has sparked internal challenges and legal opposition from Elon Musk. read more
WiMi Hologram Shares Are Up Friday: What’s Going On?
Shares of WiMi Hologram Cloud Inc. (NASDAQ: WIMI) are trading higher Friday from possible continued momentum. The company announced a new development in quantum computing technology Thursday. read more
‘Owning Bitcoin Is Digital Real Estate,’ Says Anthony Pompliano
As the global race for Bitcoin (CRYPTO: BTC) adoption intensifies, Anthony Pompliano, founder and CEO of Professional Capital Management, has issued a stark warning: if the United States does not prioritize Bitcoin, it risks falling behind as read more
What’s Going On With Vor Biopharma Shares Friday?
Vor shares are higher lower on Friday after the company announced it has entered into a securities purchase agreement for a private investment in public equity financing. read more
J.B. Hunt’s Intermodal Growth Shows Promise Despite Lagging ‘Big Three’ Ports: Analyst
Goldman Sachs analyst maintains a Buy rating on J.B. Hunt, citing positive growth potential despite its intermodal growth lagging behind the “Big Three” ports. Latest Ratings for JBHT Date Firm Action From To Mar 2022 Goldman Sachs Upgrades Neutral Buy Feb 2022 JP Morgan Upgrades Underweight Neutral Jan 2022 Barclays Upgrades Equal-Weight Overweight View More…
Johnson & Johnson Death Cross: Stock Stumbles Despite Pipeline Promise
Johnson & Johnson (NYSE:JNJ) enters bearish pattern, death cross, but strong dividends & strategic moves in dermatology provide long-term appeal. read more